Exploring the Relation Between Coexisting Chronic Lymphocytic Leukemia and Lung Cancer: Two Case Reports

探讨慢性淋巴细胞白血病与肺癌共存的关系:两例病例报告

阅读:1

Abstract

Chronic lymphocytic leukemia (CLL) is a low-grade lymphoproliferative disorder characterized by clonal proliferation of lymphocytes. The disease is indolent but might be complicated with life-threatening cytopenias, high-grade transformation, or second primary malignancies (SPMs). The incidence of SPMs is higher in CLL compared to the normal population; however, the genetic association and predisposing factors linking CLL to SPMs remain unclear. Synchronous or metasynchronous CLL and lung cancer are relatively uncommon, and the relationship is rarely explored in the literature. We report two cases of a 77-year-old male and a 52-year-old female with a history of heavy smoking, both presenting with respiratory symptoms. Imaging revealed lung masses, hilar adenopathy, pleural effusions, and visceral metastasis. The first case's pleural fluid cytology was positive for both CLL and adenocarcinoma, while the second patient was diagnosed with a biopsy from the right supraclavicular mass revealing carcinoma. In both patients, a flow cytometry of the peripheral smear confirmed the diagnosis of CLL. Both patients had a similar outcome of death due to complicated intracerebral metastatic disease with intracranial hemorrhage and vasogenic edema within 1-2 months of diagnosis. Although incompletely understood, CLL and lung cancer share some predisposing social and biological factors, of which smoking is the most evident. It is also thought that the immunocompromised state of CLL patients is a risk factor for SPMs, given qualitative and quantitative defects in almost all immune cell lines. The cytogenetic association has been suggested but has yet to be comprehensively explored. The proposed tumor factors include HER-2/neu overexpression in lung cancer cells and Trisomy 12 in B-cell clones, which neither of our patients had. Despite suggested links, the relationship between CLL and lung cancer needs further exploration which might offer a future benefit for anticipation and earlier detection of lung cancer in CLL patients.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。